Preformulation studies for the development of a microemulsion formulation from Ambrosia peruviana All., with anti-inflammatory effect
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , , , |
Tipo de documento: | Artigo |
Idioma: | eng |
Título da fonte: | Brazilian Journal of Pharmaceutical Sciences |
Texto Completo: | https://www.revistas.usp.br/bjps/article/view/213091 |
Resumo: | Natural products are considered an important source of the therapeutic arsenal currently available. Among these alternatives are the seeds of Ambrosia peruviana (altamisa), whose extract has shown an anti-inflammatory effect. The main objective of this work was to perform a preformulation study of Ambrosia peruviana seeds ethanolic extract, where the main factors that affect the physical, chemical, and pharmacological stability of the extract were evaluated, as well as a compatibility study by differential scanning calorimetry (DSC) analysis against different excipients. A dry extract was obtained by rotary evaporation of the seeds macerated with 96% ethanol. The anti-inflammatory activity was determined by measuring its effect on NO production in RAW 264.7 macrophages, stimulated with LPS. The results showed that the dry extract maintained its stability over time when stored at a temperature of 4 and 25ºC, demonstrating its biological activity, the content of phenolic compounds, and its physicochemical parameters remain practically invariable. However, when exposed to high temperatures (60 ºC) it was affected. The thermal analysis revelated that the behavior of most of the selected excipients and the dry extract was maintained, which indicates that it did not present incompatibilities, therefore they can be candidates for formulating a microemulsion. |
id |
USP-31_a5a107aee6099647ce12058402598937 |
---|---|
oai_identifier_str |
oai:revistas.usp.br:article/213091 |
network_acronym_str |
USP-31 |
network_name_str |
Brazilian Journal of Pharmaceutical Sciences |
repository_id_str |
|
spelling |
Preformulation studies for the development of a microemulsion formulation from Ambrosia peruviana All., with anti-inflammatory effectAmbrosia peruvianaPreformulationStability testExcipient compatibility studyMicroemulsionNatural products are considered an important source of the therapeutic arsenal currently available. Among these alternatives are the seeds of Ambrosia peruviana (altamisa), whose extract has shown an anti-inflammatory effect. The main objective of this work was to perform a preformulation study of Ambrosia peruviana seeds ethanolic extract, where the main factors that affect the physical, chemical, and pharmacological stability of the extract were evaluated, as well as a compatibility study by differential scanning calorimetry (DSC) analysis against different excipients. A dry extract was obtained by rotary evaporation of the seeds macerated with 96% ethanol. The anti-inflammatory activity was determined by measuring its effect on NO production in RAW 264.7 macrophages, stimulated with LPS. The results showed that the dry extract maintained its stability over time when stored at a temperature of 4 and 25ºC, demonstrating its biological activity, the content of phenolic compounds, and its physicochemical parameters remain practically invariable. However, when exposed to high temperatures (60 ºC) it was affected. The thermal analysis revelated that the behavior of most of the selected excipients and the dry extract was maintained, which indicates that it did not present incompatibilities, therefore they can be candidates for formulating a microemulsion.Universidade de São Paulo. Faculdade de Ciências Farmacêuticas2023-06-13info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionapplication/pdfhttps://www.revistas.usp.br/bjps/article/view/21309110.1590/s2175-97902023e22505 Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023)Brazilian Journal of Pharmaceutical Sciences; v. 59 (2023)Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023)2175-97901984-8250reponame:Brazilian Journal of Pharmaceutical Sciencesinstname:Universidade de São Paulo (USP)instacron:USPenghttps://www.revistas.usp.br/bjps/article/view/213091/195065Copyright (c) 2023 Brazilian Journal of Pharmaceutical Scienceshttps://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccess Palacio Taborda, Yuri PaolaCastro, Jenny Bassani, Valquiria Linck FrancO, Luis AlbertoBernal Rodríguez, Carlos-Alberto2023-06-13T14:28:34Zoai:revistas.usp.br:article/213091Revistahttps://www.revistas.usp.br/bjps/indexPUBhttps://old.scielo.br/oai/scielo-oai.phpbjps@usp.br||elizabeth.igne@gmail.com2175-97901984-8250opendoar:2023-06-13T14:28:34Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP)false |
dc.title.none.fl_str_mv |
Preformulation studies for the development of a microemulsion formulation from Ambrosia peruviana All., with anti-inflammatory effect |
title |
Preformulation studies for the development of a microemulsion formulation from Ambrosia peruviana All., with anti-inflammatory effect |
spellingShingle |
Preformulation studies for the development of a microemulsion formulation from Ambrosia peruviana All., with anti-inflammatory effect Palacio Taborda, Yuri Paola Ambrosia peruviana Preformulation Stability test Excipient compatibility study Microemulsion |
title_short |
Preformulation studies for the development of a microemulsion formulation from Ambrosia peruviana All., with anti-inflammatory effect |
title_full |
Preformulation studies for the development of a microemulsion formulation from Ambrosia peruviana All., with anti-inflammatory effect |
title_fullStr |
Preformulation studies for the development of a microemulsion formulation from Ambrosia peruviana All., with anti-inflammatory effect |
title_full_unstemmed |
Preformulation studies for the development of a microemulsion formulation from Ambrosia peruviana All., with anti-inflammatory effect |
title_sort |
Preformulation studies for the development of a microemulsion formulation from Ambrosia peruviana All., with anti-inflammatory effect |
author |
Palacio Taborda, Yuri Paola |
author_facet |
Palacio Taborda, Yuri Paola Castro, Jenny Bassani, Valquiria Linck FrancO, Luis Alberto Bernal Rodríguez, Carlos-Alberto |
author_role |
author |
author2 |
Castro, Jenny Bassani, Valquiria Linck FrancO, Luis Alberto Bernal Rodríguez, Carlos-Alberto |
author2_role |
author author author author |
dc.contributor.author.fl_str_mv |
Palacio Taborda, Yuri Paola Castro, Jenny Bassani, Valquiria Linck FrancO, Luis Alberto Bernal Rodríguez, Carlos-Alberto |
dc.subject.por.fl_str_mv |
Ambrosia peruviana Preformulation Stability test Excipient compatibility study Microemulsion |
topic |
Ambrosia peruviana Preformulation Stability test Excipient compatibility study Microemulsion |
description |
Natural products are considered an important source of the therapeutic arsenal currently available. Among these alternatives are the seeds of Ambrosia peruviana (altamisa), whose extract has shown an anti-inflammatory effect. The main objective of this work was to perform a preformulation study of Ambrosia peruviana seeds ethanolic extract, where the main factors that affect the physical, chemical, and pharmacological stability of the extract were evaluated, as well as a compatibility study by differential scanning calorimetry (DSC) analysis against different excipients. A dry extract was obtained by rotary evaporation of the seeds macerated with 96% ethanol. The anti-inflammatory activity was determined by measuring its effect on NO production in RAW 264.7 macrophages, stimulated with LPS. The results showed that the dry extract maintained its stability over time when stored at a temperature of 4 and 25ºC, demonstrating its biological activity, the content of phenolic compounds, and its physicochemical parameters remain practically invariable. However, when exposed to high temperatures (60 ºC) it was affected. The thermal analysis revelated that the behavior of most of the selected excipients and the dry extract was maintained, which indicates that it did not present incompatibilities, therefore they can be candidates for formulating a microemulsion. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-06-13 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/213091 10.1590/s2175-97902023e22505 |
url |
https://www.revistas.usp.br/bjps/article/view/213091 |
identifier_str_mv |
10.1590/s2175-97902023e22505 |
dc.language.iso.fl_str_mv |
eng |
language |
eng |
dc.relation.none.fl_str_mv |
https://www.revistas.usp.br/bjps/article/view/213091/195065 |
dc.rights.driver.fl_str_mv |
Copyright (c) 2023 Brazilian Journal of Pharmaceutical Sciences https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
Copyright (c) 2023 Brazilian Journal of Pharmaceutical Sciences https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
publisher.none.fl_str_mv |
Universidade de São Paulo. Faculdade de Ciências Farmacêuticas |
dc.source.none.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023) Brazilian Journal of Pharmaceutical Sciences; v. 59 (2023) Brazilian Journal of Pharmaceutical Sciences; Vol. 59 (2023) 2175-9790 1984-8250 reponame:Brazilian Journal of Pharmaceutical Sciences instname:Universidade de São Paulo (USP) instacron:USP |
instname_str |
Universidade de São Paulo (USP) |
instacron_str |
USP |
institution |
USP |
reponame_str |
Brazilian Journal of Pharmaceutical Sciences |
collection |
Brazilian Journal of Pharmaceutical Sciences |
repository.name.fl_str_mv |
Brazilian Journal of Pharmaceutical Sciences - Universidade de São Paulo (USP) |
repository.mail.fl_str_mv |
bjps@usp.br||elizabeth.igne@gmail.com |
_version_ |
1800222918133678080 |